Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
Apr 29, 16:00
Infinity Pharmaceuticals Profit Margin (Quarterly): -1.71K% for June 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -1.71K% |
| March 31, 2023 | -1.51K% |
| December 31, 2022 | -1.70K% |
| September 30, 2022 | -1.51K% |
| June 30, 2022 | -1.75K% |
| March 31, 2022 | -1.91K% |
| December 31, 2021 | -2.58K% |
| September 30, 2021 | -2.50K% |
| June 30, 2021 | -2.20K% |
| March 31, 2021 | -2.49K% |
| December 31, 2020 | -2.43K% |
| September 30, 2020 | -1.92K% |
| June 30, 2020 | -2.63K% |
| March 31, 2020 | -2.54K% |
| December 31, 2019 | -3.70K% |
| September 30, 2019 | -3.33K% |
| June 30, 2019 | -4.09K% |
| March 31, 2019 | -641.6% |
| December 31, 2018 | -5.63K% |
| September 30, 2018 | 60.82% |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -118.4% |
| June 30, 2017 |
| Date | Value |
|---|---|
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | -439.3% |
| December 31, 2015 | -431.7% |
| September 30, 2015 | 46.88% |
| June 30, 2015 | -787.5% |
| March 31, 2015 | -2.14K% |
| December 31, 2014 | -926.1% |
| September 30, 2014 | 64.25% |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | -66.91% |
| March 31, 2012 | -42.54% |
| December 31, 2011 | -62.98% |
| September 30, 2011 | -51.26% |
| June 30, 2011 | -58.78% |
| March 31, 2011 | -8.48% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.09K%
Minimum
Jun 2019
-1.51K%
Maximum
Sep 2022
-2.38K%
Average
-2.43K%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| Athersys Inc | -- |
| Merck & Co Inc | 30.19% |
| MEI Pharma Inc | -- |
| Humanigen Inc | -1.89K% |
| Bristol-Myers Squibb Co | -100.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -99.01% |
| Gross Profit Margin (Quarterly) | 39.62% |
| Operating Margin (Quarterly) | -1.74K% |
| Return on Net Operating Assets | -1.19K% |